Log in to search using one of your social media accounts:

 

Keller @ Large: Rep. Stephen Lynch ‘ Stunned ’ By Opioid Maneuvering In Congress

BOSTON (CBS) – Rep. Stephen Lynch (D-8th District) says he was “stunned” by the March 2016 maneuvering by GOP leaders in Congress to pass a bill curbing federal power to crackdown on suspected opioid distribution scofflaw. “It never came up for a roll call vote,” Lynch said. Instead, as a 60 Minutes/Washington Post expose has documented, the bill breezed through both branches by unanimous consent – no debate or vote – before being signed into law by then-President Obama. “This was treated like the naming of a post office or something like that,” says Lynch in a WBZ-TV interview that will air this Sunday, Oct. 22, at 8:30 a.m. “The House and Senate leaders have the prerogative of looking at bills and saying what’s controversial and what’s not.” And Lynch says this is hardly the first time opioid industry lobbyists have had their way with Congress. “Back in 2006 I had a bill, very basic, to ban Oxycontin, because I saw the high addiction rate in my district,” he says. “I never had a chance because of all the lobbyists working on behalf of the pharmaceutical companies.” Public and political backlash against this latest backroom move has already killed the nomination of Congressman Tom Marino (R-Pennsylvania), a lead sponsor of the bill, to be national drug czar. And Lynch says the fallout isn’t over. “I think it shocked a lot of people and I think that helps us with ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health Local News Politics Syndicated Local Jon Keller Keller @ Large opioid crisis Rep Stephen Lynch Source Type: news

Related Links:

Oncogenic addiction to the Fms-like tyrosine kinase 3 (FLT3) is a hallmark of acute myeloid leukemia (AML) that harbors the FLT3–internal tandem duplication (FLT3-ITD) mutation. While FLT3 inhibitors like sorafenib show initial therapeutic efficacy, resistance rapidly develops through mechanisms that are incompletely understood. Here, we used RNA-Seq–based analysis of patient leukemic cells and found that upregulation of the Tec family kinase BMX occurs during sorafenib resistance. This upregulation was recapitulated in an in vivo murine FLT3-ITD–positive (FLT3-ITD+) model of sorafenib resistance. Mechani...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
Hello! I'm a new PMHNP. I had my schooling paid for by the NURSE Corps scholarship so I'm debt free and working in an underserved community for the next two years. I did research assisting in college and really thought I wanted out of academia. I was so ready to be done with that environment. However, I am realizing that I'm so passionate about so many issues, especially in addiction psychiatry. I'm not the best writer or the smartest person. I am also very fiscally practical when it... PMHNP with Master's to PhD in Nursing? Worth it?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Source Type: forums
Publication date: 11 December 2017 Source:Cancer Cell, Volume 32, Issue 6 Author(s): Severa Bunda, Gelareh Zadeh, Kenneth D. Aldape The link between GBM molecular subtype and response to treatment remains undefined. In this issue of Cancer Cell, Cosset and colleagues define a subpopulation of patients within the proneural/classical subtype sensitive to integrin blockade because of a Glut3 addiction. These findings reveal context-dependent druggable vulnerability in a subpopulation of GBM. Teaser The link between GBM molecular subtype and response to treatment remains undefined. In this issue of Cancer Cell, Cosset and col...
Source: Cancer Cell - Category: Cancer & Oncology Source Type: research
Abstract Infants with low‐grade glioma (LGG) and diencephalic syndrome have a poor outcome. The patient described here had a desmoplastic infantile astrocytoma harboring a BRAF V600E mutation. After relapse following initial standard chemotherapy treatment, he was successfully treated with the BRAF V600E inhibitor vemurafenib at the age of 3 years 11 months and 5 years 0 months. A rapid response was observed on both occasions. This illustrates the possibility of continuous oncogenic addiction and the therapeutic potential of BRAF V600E inhibitor monotherapy in LGG, even in very young severely compromised children. BRAF V...
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Tags: BRIEF REPORT Source Type: research
Publication date: Available online 11 December 2017 Source:The Arts in Psychotherapy Author(s): Jeff Gordon, Yoram Shenar, Susana Pendzik This paper presents an innovative drama therapy approach to working with addiction using “Clown therapy” −a process through which the clients are led to discover their inner Clown. Using drama therapy techniques, each client’s key/dominant and oppositional personality roles are recognized and brought together through embodiment, leading to the emergence of the Clown. The paper presents the theoretical and practical foundation of the approach, linking it to drama ...
Source: Arts in Psychotherapy - Category: Psychiatry & Psychology Source Type: research
We are coming up that *that* time of year. Your calendar is top heavy. Perhaps like me you’re having to endure the lights on the house next door bursting into a rendition of ‘deck the halls with boughs of holly’ every time a person walks past and triggers the motion sensor, and self development bloggers the Internet over are salivating at the thought of writing about setting New Years resolutions. If you’re reading my blog then it’s doubtful you’re a self development rookie. You know the score. You know that most New Years resolutions have a shelf life not much longer than the sagging Ch...
Source: A Daring Adventure - Category: Psychiatry & Psychology Authors: Tags: Life Coaching Source Type: blogs
Read clinically focused news coverage of key developments from AAAP 2017Medscape Psychiatry
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Conference Coverage Source Type: news
Conditions:   HIV/AIDS;   HIV Infections;   Substance Use;   Substance Abuse;   Substance Use Disorders;   Sexually Transmitted Diseases Intervention:   Behavioral: Link2CARE Sponsors:   New York State Psychiatric Institute;   Center for Court Innovation;   The National Center on Addiction and Substance Abuse at Columbia University;   National Institute on Drug Abuse (NIDA);   Columbia University Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Smartphones may be our latest vice. The effects on young people are especially concerning.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
Excerpted from A Parent’s Guide to Teen Addiction: Professional Advice on Signs, Symptoms, What to Say, and How to Help (Skyhorse Publishing) by Laurence M. Westreich, M.D. Marijuana, the illegal drug most commonly used by teenagers, is widely accepted as harmless, but is it? Its effects range from the trivial — silliness, bloodshot eyes, etc. — all the way to catastrophic — paranoia, depression, and more. Many teenagers and parents don’t realize that although not as potent, it’s a hallucinogen similar to LSD and Ecstasy. Marijuana and the other hallucinogens can cause serious problems f...
Source: Psych Central - Category: Psychiatry Authors: Tags: Addictions Children and Teens Parenting Substance Abuse cannabis Communication Marijuana marijuana abuse recovery Teen Addiction Teen Substance Abuse Source Type: news
More News: Addiction | American Health | Health | Obama | Oxycodone | OxyContin | Politics | Sports Medicine | USA Health